Subpopulations (%) | All patients with RMS | Control group | Р |
CD3+ HLADR+ | 35.5 ± 6.0 (n = 15) | 12.5 ± 2.0 (n = 12) | 0.003 |
CD8+ HLADR+ | 28.7 ± 6.1 (n = 10) | 8.9 ± 1.4 (n = 11) | 0.001 |
γδTCR Т cells | 15.7 ± 1.6 (n = 11) | 9.6 ± 1.5 (n = 10) | 0.013 |